101 related articles for article (PubMed ID: 1675187)
1. [Perspectives in the clinical utilization of molecular biology findings].
Schreiber G; Schreiber S; Bender HG
Gynakologe; 1991 Feb; 24(1):17-21. PubMed ID: 1675187
[No Abstract] [Full Text] [Related]
2. Oncogenes and their mechanisms of action.
Găldean D
Roum Arch Microbiol Immunol; 1992; 51(1-2):75-99. PubMed ID: 1457825
[No Abstract] [Full Text] [Related]
3. Control of tumor virus expression by host cell genes.
zur Hausen H
Immunol Ser; 1990; 51():107-21. PubMed ID: 1965698
[No Abstract] [Full Text] [Related]
4. Oncogenes and oncogenesis.
Currie GA
Clin Oncol; 1984 Jun; 10(2):97-101. PubMed ID: 6734013
[No Abstract] [Full Text] [Related]
5. [Carcinogenesis: viruses and transposons].
Zhdanov VM
Vopr Onkol; 1984; 30(1):98-104. PubMed ID: 6320545
[No Abstract] [Full Text] [Related]
6. The role of oncogenes in the pathogenesis of cancer.
van Ormondt H; van der Eb AJ
Neth J Med; 1986; 29(2):49-52. PubMed ID: 3951653
[No Abstract] [Full Text] [Related]
7. The p53 tumour suppressor gene.
Levine AJ; Momand J; Finlay CA
Nature; 1991 Jun; 351(6326):453-6. PubMed ID: 2046748
[TBL] [Abstract][Full Text] [Related]
8. [Oncogens. Their origin, distribution, structure and functions in carcinogenesis].
Seits IF; Kniazev PG; Fedorov SN
Vopr Onkol; 1982; 28(10):95-114. PubMed ID: 6755899
[No Abstract] [Full Text] [Related]
9. [Molecular genetic aspects of solid tumors. Presentation of modern study approaches exemplified by renal cell cancer].
Strohmeyer T; Ackermann R
Med Klin (Munich); 1993 Jan; 88(1):28-34. PubMed ID: 8094882
[No Abstract] [Full Text] [Related]
10. The genetic origins of human cancer.
Weinberg RA
Cancer; 1988 May; 61(10):1963-8. PubMed ID: 3282638
[No Abstract] [Full Text] [Related]
11. Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation.
Brodeur GM
Prog Hematol; 1986; 14():229-56. PubMed ID: 3003796
[No Abstract] [Full Text] [Related]
12. [The oncogenes].
Lévy JP
Rev Prat; 1988 Jan; 38(1):55-61. PubMed ID: 3278361
[No Abstract] [Full Text] [Related]
13. [Viral and cellular oncogenes].
Biserte G
Bull Acad Natl Med; 1985 Oct; 169(7):1029-36. PubMed ID: 3914320
[No Abstract] [Full Text] [Related]
14. The functions of oncogene products.
Hunter T
Prog Clin Biol Res; 1989; 288():25-34. PubMed ID: 2541449
[No Abstract] [Full Text] [Related]
15. Suppressors of the malignant phenotype.
Mikkelsen T; Cavenee WK
Cell Growth Differ; 1990 Apr; 1(4):201-7. PubMed ID: 2128032
[No Abstract] [Full Text] [Related]
16. [New antigens induced by oncogenic viruses].
Kosiakova NP
Usp Sovrem Biol; 1982; 93(3):433-47. PubMed ID: 7051606
[No Abstract] [Full Text] [Related]
17. [Notes on the mode of action of oncogenic viruses].
Leone G
Arch Sci Med (Torino); 1973; 130(2):158-68. PubMed ID: 17342927
[TBL] [Abstract][Full Text] [Related]
18. Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas.
Wagata T; Ishizaki K; Imamura M; Shimada Y; Ikenaga M; Tobe T
Cancer Res; 1991 Apr; 51(8):2113-7. PubMed ID: 1826231
[TBL] [Abstract][Full Text] [Related]
19. [Genetics and cancer].
Cardesa JJ; Blesa E; Durán J; Moreno F; Espinosa J; Zarallo L
An Esp Pediatr; 1985 Aug; 23(2):116-22. PubMed ID: 2998249
[No Abstract] [Full Text] [Related]
20. [Polymorphic changes in cellular phenotype during hyperexpression of the NEU proto-oncogene].
Tarakhovskiĭ AM; Reznikov V; Zaĭchuk TA; Sakharova NK; Butenko ZA
Dokl Akad Nauk SSSR; 1989; 306(1):217-21. PubMed ID: 2568901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
